[ad_1]
“Yes, we have received information that the previous quantity for Lithuania has been reduced by 80 percent. In other words, it is planned to deliver only a fifth of the agreed quantity of vaccine in the first quarter,” said Buk A. Šuksta Saturday.
He said he could not reveal the exact number of planned and future vaccines.
AstraZeneca warned on Friday that its supply of coronavirus vaccines to Europe would be “less than initially expected.” The company explained this by “reduced productivity at the production site within our European supply chain”, but did not provide further details.
According to Reuters, the company plans to reduce its planned vaccine supply to the Community by 60 percent in the first quarter, to 31 million. dose.
The prime ministers of the Baltic countries on Friday asked the institutions of the European Union to allow the export of the AstraZeneca vaccine developed by the British before its formal approval, thus contributing to the call announced by Denmark, Greece, Austria and the Czech Republic at the beginning of this year. week.
The vaccine, developed in collaboration with the University of Oxford, is already being distributed in Britain, but has not yet been approved by the European Union. A decision on its distribution in the Community is expected to be made before January 29.
It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.
[ad_2]
